Synthes gets US nod for thoracic disorder implant
This article was originally published in Clinica
The US FDA has approved for sale an implantable device for treating children with thoracic insufficiency syndrome (TIS)- severe deformities of the chest, spine, and ribs that prevent normal breathing and lung development.
You may also be interested in...
Gallium has been approved as a diagnostic agent by the US agency to help early detection of prostate cancer spread in patients who qualify for treatment with surgery or radiation therapy.
A joint report by the US Government Accountability Office and the National Academy of Sciences slams the FDA for dawdling on final software as a medical device rules.
Canada has announced new restrictions on exports to help mitigate the impact of measures in the US to lower medicine prices there.